The global bicuspid aortic valve disease market size was valued at USD 14.90 billion in 2024 and is expected to reach USD 23.75 billion by 2032, at a CAGR of 6.00% during the forecast period
The market growth is primarily driven by the increasing prevalence of congenital heart conditions and improved diagnostic capabilities that enable early detection and management of bicuspid aortic valve anomalies
In addition, advancements in minimally invasive surgical
procedures, valve replacement technologies, and patient-specific treatment planning are strengthening the therapeutic landscape. These developments, combined with rising healthcare awareness and investment in cardiac care, are propelling the demand for effective solutions, thereby significantly boosting the industry's growth